Fig. 1

Median age at disease onset (a), prevalence of uveitis (b) and ANA positivity (c) in patients with RF negative polyarthritis included in the EPOCA study across the world
Median age at disease onset (a), prevalence of uveitis (b) and ANA positivity (c) in patients with RF negative polyarthritis included in the EPOCA study across the world